SHANGHAI, May 8, 2024
/PRNewswire/ -- Andall Biosciences Inc. (ABI), a renowned
biotechnology company at the forefront of life science research and
applications, has made a significant stride with the introduction
of their groundbreaking new product line, 23WELL. The brand takes
center stage with its debut offering, Ovary Care Capsules (1+1) at
Circle Harmony, a high-end medical service institution located
within InterContinental Shanghai Ruijin. This innovative product
has already received Certificate of Free Sale from the U.S. Food
and Drug Administration (FDA), highlighting ABI's commitment to
bridging the gap between therapeutic treatment and preventative
treatment and supporting healthier and better lives for more
families. This revolutionary new product, 23WELL Ovary Care
Capsules (1+1), is dedicated to women's health, specifically ovary
care. Notably, ABI has already applied for patents for their
pioneering method of preparing these extracts in China, the United
States, and the United
Kingdom, underscoring its commitment to cutting-edge
biotechnology.
23WELL, inspired by the 23 chromosomes that are the building
blocks of life, combines advanced life science research with the
power of natural ingredients. This brand seamlessly integrates
cutting-edge life science research with the power of natural
ingredients, creating practical health supplements that promote
enhanced well-being for consumers. With an unwavering commitment to
excellence, 23WELL employs meticulous selection processes to ensure
only the finest raw materials are utilized. Furthermore, the
capsules are meticulously produced within a facility that meets the
Class 100,000 GMP Cleanroom requirement, utilizing customized
production lines that adhere to strict standards. With 23WELL, ABI
delivers a brand that not only represents premium quality but also
champions the pursuit of optimal health.
"As a scientist committed to meaningful innovation, I'm excited
about the promise of 23WELL's first product. With this pioneering
offering, we embark on a journey of limitless potential, laying the
foundation for a brand that will transcend boundaries and
revolutionize the world of innovation," said James Martin Roza, Contracted Scientist of
23WELL and American Representative of Codex Alimentarius Commission
(CAC).
"As a woman, the importance of caring for one's reproductive
health is a matter that resonates with me profoundly. While
skincare often takes precedence for many women, it is crucial to
recognize that holistic well-being surpasses mere external beauty.
The Ovary Care Capsules (1+1) are born from a vision to shift the
self-care paradigm for women, placing a heightened emphasis on
reproductive health alongside traditional skincare routines. Under
the banner of our new brand – 23WELL, our mission is to
continuously stay abreast of the latest breakthroughs in life
sciences, genetics, and clinical medicine. We strive to integrate
state-of-the-art medical technologies with natural ingredients,
thereby promoting global health and well-being," said Helen Li, Founder and Chief Research Officer of
ABI.
Product highlights:
- Owned technology SREC-BIOTECH ensures the stability of
each ingredient.
- 23WELL introduces its Ovary Care Capsules in a special 1+1
offer, uniquely blending the best of Western and Chinese medicinal
traditions. The product features FoxOEN & FoxORE
Complex, with advanced ingredients like Myo-Inositol, Coenzyme Q10,
and Vitamins E and D, and traditional Chinese elements such as
Gallus Domesticus Peptide and Astragalus Root Extract.
ABI has reached remarkable milestones on its journey, including
its official entry into the Chinese market in 2023 with a
collection of five high-end and high-tech dietary health
supplements. Unlike many brands produced by outsourcing factories,
ABI has its own well-equipped factory located in California, USA, with a daily output of up to
10 million capsules. Furthermore, the brand has invited renowned
TikTok influencers, Zhang Meng and
Jiaoge Pengyou MCN, to personally experience the production process
at its California facility. This
on-site visit provided an opportunity for the influencers to
witness each step of production and gain a firsthand understanding
of ABI's meticulous approach.
With its dedication to innovation, quality, and consumer
well-being, ABI continues to strive towards a healthier and better
future for people worldwide. By offering a diverse range of dietary
supplements and pushing the boundaries of scientific research, ABI
aims to provide more choices and empower individuals to achieve a
lifestyle that fosters vitality and well-being. 23WELL's
exceptional focus on integrating traditional Chinese and Western
medicines in their new product represents a groundbreaking
achievement and a reminder for women to take proactive measures to
prevent potential health issues. Ovarian health contributes to
women's vitality, yet the global incidence rate of premature
ovarian insufficiency (POI) stands at approximately 3.7%, while in
China, it reaches around 10%.
ABI's dedication to women's health will always remain at the
forefront of their efforts, ensuring a brighter and healthier
future for women worldwide. For more information, please visit
https://www.andall-health.com.
*These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/andall-biosciences-introduces-23well-a-breakthrough-new-brand-with-ovary-care-capsules-11-as-its-stellar-debut-product-302139623.html
SOURCE Andall Biosciences Inc.